Minerva Surgical, Inc. provided revenue guidance for the full year 2022. The company expects full year 2022 revenue in the range of $60 million to $63 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 USD | +1,000.00% | +1,000.00% | -99.06% |
Jan. 03 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-99.06% | 97.66K | |
+14.42% | 131B | |
-15.80% | 7.33B | |
+42.18% | 5.69B | |
-20.14% | 4.83B | |
+8.58% | 3.45B | |
-19.51% | 2.47B | |
-17.70% | 1.93B | |
-19.46% | 1.79B | |
-34.15% | 1.52B |
- Stock Market
- Equities
- UTRS Stock
- News Minerva Surgical, Inc.
- Minerva Surgical, Inc. Provides Revenue Guidance for the Full Year 2022